Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare familial cardiomyopathy characterized by the dilation of left ventricle and progressively impairing of systolic ventricular function, in the absence of abnormal loading conditions or coronary artery disease sufficient to cause global systolic impairment. The disease may cause heart failure or arrhythmia. The disease is isolated when no additional atypical cardiac or extracardiac manifestations are present.
Features include very common findings: Enlarged and weakened heart (dilated cardiomyopathy) and Left ventricular systolic dysfunction; and common findings: Edema, Congestive heart failure, Exertional dyspnea, and Arrhythmia and others. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 5 | Enlarged and weakened heart (dilated cardiomyopathy), Left ventricular systolic dysfunction, Congestive heart failure |
Biomarker and diagnostic research for familial isolated dilated cardiomyopathy has been reported in the published literature.
Phenotype severity distribution: 2 very common features, 6 common features.
Estimated prevalence: 1-5 in 10,000 (Uncommon).
No clinical trials have been registered for familial isolated dilated cardiomyopathy.
189 publications have been identified in PubMed for familial isolated dilated cardiomyopathy. Research spans Basic Science / Preclinical (34%), Epidemiology / Natural History (17%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 64 | 34% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 5:34 AM UTC
European rare disease database
Brain and nerves | 2 | Fatigue, Thromboembolic stroke |
Lungs and breathing | 1 | Exertional dyspnea |
Ears | 1 | Inner ear hearing loss (sensorineural hearing impairment) |
Muscles | 1 | Myopathy |
Lab test results | 1 | Abnormal electrical muscle activity (EMG) (emg abnormality) |
Age of onset: adulthood, infancy, at birth.
Disease patterns and progression
33 |
17% |
Research summaries | 24 | 13% |
Testing and diagnosis research | 18 | 10% |
Clinical study results | 18 | 10% |
New treatment approaches | 15 | 8% |
Patient case studies | 14 | 7% |
Other research | 3 | 2% |
Kervella M (2026). [PMID: 41841259](https://pubmed.ncbi.nlm.nih.gov/41841259/). *Circ Heart Fail*. [Gene Therapy / Novel Therapeutics]
Liu CF (2026). [PMID: 41265985](https://pubmed.ncbi.nlm.nih.gov/41265985/). *Heart failure clinics*. [Clinical Trial Publication]
Angelotti A (2026). [PMID: 41453508](https://pubmed.ncbi.nlm.nih.gov/41453508/). *J Mol Cell Cardiol*. [Basic Science / Preclinical]
Saha S (2026). [PMID: 41343200](https://pubmed.ncbi.nlm.nih.gov/41343200/). *Am J Physiol Heart Circ Physiol*. [Diagnostic / Biomarker]
Oguri G (2026). [PMID: 41521401](https://pubmed.ncbi.nlm.nih.gov/41521401/). *Physiol Rep*. [Basic Science / Preclinical]
Bonanni F (2026). [PMID: 41202887](https://pubmed.ncbi.nlm.nih.gov/41202887/). *Int J Cardiol*. [Epidemiology / Natural History]
Li F (2026). [PMID: 42222889](https://pubmed.ncbi.nlm.nih.gov/42222889/). *J Clin Invest*. [Gene Therapy / Novel Therapeutics]
Mora-Ayestarán N (2026). [PMID: 41067410](https://pubmed.ncbi.nlm.nih.gov/41067410/). *Rev Esp Cardiol (Engl Ed)*. [Epidemiology / Natural History]
Wang H (2026). [PMID: 41948821](https://pubmed.ncbi.nlm.nih.gov/41948821/). *Circ Res*. [Basic Science / Preclinical]
Chen ZY (2026). [PMID: 41545752](https://pubmed.ncbi.nlm.nih.gov/41545752/). *Acta Pharmacol Sin*. [Gene Therapy / Novel Therapeutics]